Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

3,360.00p
   
  • Change Today:
    -30.00p
  • 52 Week High: 4,100.00p
  • 52 Week Low: 2,950.00p
  • Currency: UK Pounds
  • Shares Issued: 5.14m
  • Volume: 478
  • Market Cap: £172.79m
  • Beta: 0.18

Latest ShareCast News

Bioventix full-year revenue and profits improve

By Josh White

Date: Monday 21 Oct 2019

(Sharecast News) - Bioventix, which specialises in the development and commercial supply of high-affinity monoclonal antibodies for applications in clinical diagnostics, reported a 6% improvement in revenue for the year on Monday, to £9.3m.

Vitamin D antibodies drive first-half growth at Bioventix

By Josh White

Date: Friday 29 Mar 2019

(Sharecast News) - Monoclonal antibodies developer and supplier Bioventix reported a 24% improvement in its normalised revenue in its half-year report on Friday, to £4.4m.

Bioventix posts healthy profits, ups dividend; warns of plateauing vit-D sales

By Abigail Townsend

Date: Monday 08 Oct 2018

(Sharecast News) - Aim's Bioventix announced Monday it would pay a special dividend after a strong year of revenue and profit growth - but also sounded a warning over one of its key revenue streams.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 3,360.00p
Change Today -30.00p
% Change -0.89 %
52 Week High 4,100.00p
52 Week Low 2,950.00p
Volume 478
Shares Issued 5.14m
Market Cap £172.79m
Beta 0.18

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
96.31% below the market average96.31% below the market average96.31% below the market average96.31% below the market average96.31% below the market average
89.66% below the sector average89.66% below the sector average89.66% below the sector average89.66% below the sector average89.66% below the sector average
Price Trend
26.80% above the market average26.80% above the market average26.80% above the market average26.80% above the market average26.80% above the market average
35.59% above the sector average35.59% above the sector average35.59% above the sector average35.59% above the sector average35.59% above the sector average
Income
41.72% below the market average41.72% below the market average41.72% below the market average41.72% below the market average41.72% below the market average
9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average
Growth
6.39% above the market average6.39% above the market average6.39% above the market average6.39% above the market average6.39% above the market average
31.58% above the sector average31.58% above the sector average31.58% above the sector average31.58% above the sector average31.58% above the sector average

Bioventix Dividends

  Latest Previous
  Final Special
Ex-Div 31-Oct-19 31-Oct-19
Paid 15-Nov-19 15-Nov-19
Amount 43.00p 47.00p

Trades for 06-Dec-2019

Time Volume / Share Price
13:43 125 @ 3,320.00p
13:33 151 @ 3,320.00p
11:36 115 @ 3,320.00p
10:57 38 @ 3,350.00p
09:21 49 @ 3,350.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
Finance Director Treena Joan Turner

Top of Page